论文部分内容阅读
目的:分析头孢克洛联合参苓白术颗粒、木香顺气丸对慢性胃炎的临床治疗效果。方法:选取慢性胃炎患者84例,将其随机分为实验组和对照组各42例。实验组患者采用头孢克洛、参苓白术颗粒和木香顺气丸治疗,对照组患者采用奥美拉唑、克拉霉素和阿莫西林治疗,观察比较两组患者的临床疗效。结果:经过治疗,实验组患者总有效率为95.24%,明显高于对照组的83.33%;实验组患者不良反应发生率为4.76%,低于对照组的11.90%;对照组患者复发率为9.52%,低于对照组的2.38%,差异均有统计学意义(P<0.05)。结论:采用头孢克洛联合参苓白术颗粒和木香顺气丸治疗慢性胃炎疗效显著,值得临床推广应用。
Objective: To analyze the clinical effect of cefaclor combined with Shenling Baizhu granule and Muxiang Shunqi Pill on chronic gastritis. Methods: 84 patients with chronic gastritis were selected and randomly divided into experimental group and control group, 42 cases each. Patients in the experimental group were treated with cefaclor, Shenlingbaizhu granule and Muxiang Shunqi Pill. The patients in the control group were treated with omeprazole, clarithromycin and amoxicillin. The clinical efficacy was compared between the two groups. Results: After treatment, the total effective rate of the experimental group was 95.24%, which was significantly higher than that of the control group (83.33%). The incidence of adverse reactions in the experimental group was 4.76%, lower than that of the control group (11.90%). The recurrence rate of the control group was 9.52 %, Lower than the control group 2.38%, the difference was statistically significant (P <0.05). Conclusion: The treatment of chronic gastritis with cefaclor combined with Shenling Baizhu Granule and Muxiang Shunqi Pill has obvious curative effect, which is worthy of clinical application.